Strong evidence has indicated that protein phosphatase 2A (PP2A) is a tumor suppressor, but a mouse model for testing the tumor suppressor activity was missing. The most abundant forms of trimeric PP2A holoenzyme consist of the scaffolding A␣ subunit, one of several regulatory B subunits, and the catalytic C␣ subunit. A␣ mutations were discovered in a variety of human carcinomas. All carcinoma-associated mutant A␣ subunits are defective in binding the B or B and C subunits. Here we describe two knock-in mice expressing cancer-associated A␣ point mutants defective in binding B subunits, one knockout mouse expressing truncated A␣ defective in B and C subunit binding, and a floxed mouse for generating conditional A␣ knockouts. We found that the cancer-associated A␣ mutations increased the incidence of cancer by 50 to 60% in lungs of FVB mice treated with benzopyrene, demonstrating that PP2A acts as a tumor suppressor. We show that the effect of A␣ mutation on cancer incidence is dependent on the tumor suppressor p53. The finding that the A␣ mutation E64D, which was detected in a human lung carcinoma, increases the lung cancer incidence in mice suggests that this mutation also played a role in the development of the carcinoma in which it was discovered.Protein phosphatase 2A (PP2A) plays a role in many fundamental cellular processes, such as signal transduction, DNA repair, transcription, translation, and growth control (15,24,26,43,77). The basis for this multifunctionality of PP2A rests on the large number of subunits that control its phosphatase activity, substrate specificity, and subcellular localization. The trimeric holoenzyme is composed of a catalytic C subunit, a scaffolding A subunit, and one of many regulatory B subunits. The dimeric core enzyme consists of one A and one C subunit. Both forms coexist in cultured cells and in tissue (5,30,42). The A subunit exists as two isoforms, A␣ and A, which are 87% identical. The catalytic C subunit also exists as two isoforms, C␣ and C, which are 96% identical. The B subunits fall into four families designated B, BЈ, BЉ, and Bٞ. The B or PR55 family has four members, the BЈ family (also designated B56 or PR61) consists of five isoforms and additional splice variants, and the BЉ or PR72 family has four members, including splice variants. B, BЈ, and BЉ are largely unrelated by sequence except for two common regions involved in binding to the A subunit (34). The Bٞ family has two members, striatin and S/G 2 nuclear autoantigen (40). The combination of all subunits could give rise to over 70 different holoenzymes. In addition, the ability of PP2A to associate with approximately 150 other proteins further increases its regulatory potential (15,24,26,42). Figure 1 shows a schematic diagram of the BЈ-containing holoenzyme whose structure has been revealed by biochemical analysis (53, 56) and X-ray crystallography (9,19,44,78,79).The first indication that PP2A might be a tumor suppressor came from the finding that okadaic acid is both a tumor promoter and an inhibitor of...